In this short scribble video you can learn what CLL (Chronic Lymphocytic Leukaemia) is, what the typical signs and symptoms are, and why early diagnosis matters.

Ryan Jacobs, MD, of the Atrium Health Levine cancer Institute in Charlotte, NC, provides an overview of the current treatment landscape for patients with chronic lymphocytic leukemia (CLL).

CLL is a rare blood cancer resulting in a build-up of lymphocytes in bone marrow, lymph nodes, and blood. As Dr. Jacobs notes, many advances have been made in the past few years to provide a variety of safe and effective options for patients with CLL. Among the targeted therapies, two Bruton tyrosine kinase inhibitors (BTKIs) are currently approved by the US Food and Drug Administration (FDA) – Ibrutinib and acalabrutinib. Another targeted therapy, venetoclax, targets BCL-2, a protein on CLL cells.

To learn more about CLL and other rare cancers, visit checkrare.com/diseases/cancers/

A Short video describing treatment options for CLL

Join Leigh as she shares her experience of living with chronic lymphocytic leukaemia (CLL). Leigh is looking forward to one day seeing a cure not just for CLL but every type of cancer.

Leigh is a very positive person and is feeling well and enjoying life with her family.

The Leukaemia Foundation is there to support people, like Leigh, with blood cancer and help them navigate that journey.

Remember, discussing treatment options for CLL with your haematologist is important to ensure you are on a treatment plan that works best for you. If you’re starting a new treatment plan it’s important to find a way that works for you to build a habit and stay compliant with treatment protocols – a diary, checklist, time of day – all help to keep you on track.

Living with CLL: Hear CLL patients discuss the realities of living with the condition, as well as information about coping with diagnosis to adjusting to life with CLL.